Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
QNRX
— Quoin Pharmaceuticals, Ltd.
NASDAQ
FULL STOCK PAGE →
Q4 2023 Earnings Call Summary
MAR 14, 2024
REVENUE
$0
EPS
-$2571.15
-7.9%
FREE CASH FLOW
-$3.2M
-143.9%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →